SanegeneBio licenses RNAi candidate to Genentech for $200M upfront
SanegeneBio licenses RNAi candidate to Genentech for $200M upfront
Contenu indisponible. Consultez la source originale.
SanegeneBio licenses RNAi candidate to Genentech for $200M upfront
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.